Literature DB >> 8108389

Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

S J Siciliano1, T E Rollins, J DeMartino, Z Konteatis, L Malkowitz, G Van Riper, S Bondy, H Rosen, M S Springer.   

Abstract

The guanine nucleotide-binding protein-coupled receptor superfamily binds a vast array of biological messengers including lipids, odorants, catecholamines, peptides, and proteins. While some small molecules bind to these receptors at a single interhelical site, we find that the binding domain on the receptor for the inflammatory protein C5a is more complex and consists of two distinct subsites. This more elaborate motif appears to be an evolutionary adaptation of the simpler paradigm to which a second interaction site has been added in the receptor N terminus. Surprisingly, occupation of only one of the subsites is required for receptor activation. The two-site motif is not unique to the C5a receptor but appears to be widely used by the superfamily to accommodate macromolecular ligands.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108389      PMCID: PMC43127          DOI: 10.1073/pnas.91.4.1214

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.

Authors:  T M Fong; R R Huang; C D Strader
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity.

Authors:  G J LaRosa; K M Thomas; M E Kaufmann; R Mark; M White; L Taylor; G Gray; D Witt; J Navarro
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

3.  Improvements in the minimum binding sequence of C5a: examination of His-67.

Authors:  Y S Or; R F Clark; B Lane; K W Mollison; G W Carter; J R Luly
Journal:  J Med Chem       Date:  1992-01-24       Impact factor: 7.446

4.  The transfer and stable integration of the HSV thymidine kinase gene into mouse cells.

Authors:  A Pellicer; M Wigler; R Axel; S Silverstein
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

5.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

6.  Transformation of rat cells by DNA of human adenovirus 5.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

7.  Identification of the polymorphonuclear leukocyte C5a receptor.

Authors:  T E Rollins; M S Springer
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

Review 8.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

9.  The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1.

Authors:  H Montz; K C Koch; R Zierz; O Götze
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

10.  Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.

Authors:  I Clark-Lewis; C Schumacher; M Baggiolini; B Moser
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  52 in total

1.  A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.

Authors:  T Dragic; A Trkola; D A Thompson; E G Cormier; F A Kajumo; E Maxwell; S W Lin; W Ying; S O Smith; T P Sakmar; J P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 3.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

4.  Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues.

Authors:  Chang-Zhi Dong; Shaomin Tian; Won-Tak Choi; Santhosh Kumar; Dongxiang Liu; Yan Xu; Xiaofeng Han; Ziwei Huang; Jing An
Journal:  Biochemistry       Date:  2012-07-23       Impact factor: 3.162

5.  Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.

Authors:  J Sun; J A Ember; T H Chao; Y Fukuoka; R D Ye; T E Hugli
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

6.  Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity.

Authors:  Luca Vangelista; Renato Longhi; Francesca Sironi; Vincenzo Pavone; Paolo Lusso
Journal:  Biochem Biophys Res Commun       Date:  2006-10-26       Impact factor: 3.575

Review 7.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

Review 8.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 9.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

10.  Antagonistic peptides against human anaphylatoxin C5a.

Authors:  Y Kaneko; N Okada; L Baranyi; T Azuma; H Okada
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.